Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2018	$ 28,000	$ 76,101,000	$ (64,523,000)	$ 11,606,000
Balance, shares at Dec. 31, 2018	28,392,853
Common stock issued for directors’ fees		131,000		131,000
Common stock issued for directors’ fees, shares	147,830
Costs related to issuance of stock		(58,000)		(58,000)
Stock Compensation Expense		233,000		233,000
Other Adjustments - Shares Issued
Other Adjustments - Shares Issued, shares	144,899
Other Adjustments - Fair Value allocation		(185,000)		(185,000)
Net Income (Loss)			(923,000)	(923,000)
Balance at Mar. 31, 2019	$ 28,000	76,222,000	(65,446,000)	10,804,000
Balance, shares at Mar. 31, 2019	28,685,582
Balance at Dec. 31, 2018	$ 28,000	76,101,000	(64,523,000)	11,606,000
Balance, shares at Dec. 31, 2018	28,392,853
Balance at Sep. 30, 2019	$ 28,000	76,527,000	(65,994,000)	10,561,000
Balance, shares at Sep. 30, 2019	28,951,194
Balance at Mar. 31, 2019	$ 28,000	76,222,000	(65,446,000)	10,804,000
Balance, shares at Mar. 31, 2019	28,685,582
Issuance of Common Stock	$ 1,000	186,000		187,000
Issuance of Common Stock, shares	180,000
Stock Compensation Expense		93,000		93,000
Other Adjustments - Shares Issued
Other Adjustments - Shares Issued, shares	25,401
Share Issuance Costs		(55,000)		(55,000)
Net Income (Loss)			(735,000)	(735,000)
Balance at Jun. 30, 2019	$ 29,000	76,446,000	(66,181,000)	10,294,000
Balance, shares at Jun. 30, 2019	28,890,983
Common stock issued for directors’ fees		56,000		56,000
Common stock issued for directors’ fees, shares	57,433
Issuance of Common Stock
Issuance of Common Stock, shares	2,778
Stock Compensation Expense		25,000		25,000
Other Adjustments - Rounding	(1,000)			(1,000)
Net Income (Loss)			187,000	187,000
Balance at Sep. 30, 2019	$ 28,000	76,527,000	(65,994,000)	10,561,000
Balance, shares at Sep. 30, 2019	28,951,194
Balance at Dec. 31, 2019	$ 29,000	77,434,000	(67,257,000)	10,206,000
Balance, shares at Dec. 31, 2019	29,478,338
Common stock issued for directors’ fees		55,000		55,000
Common stock issued for directors’ fees, shares	43,771
Costs related to issuance of stock		(145,000)		(145,000)
Issuance of Common Stock	$ 1,000	983,000		984,000
Issuance of Common Stock, shares	419,597
Common Stock Issued for Convertible Notes		885,000		885,000
Common Stock Issued for Convertible Notes, shares	590,243
Stock Compensation Expense		140,000		140,000
Net Income (Loss)			1,058,000	1,058,000
Balance at Mar. 31, 2020	$ 30,000	79,352,000	(66,199,000)	13,183,000
Balance, shares at Mar. 31, 2020	30,531,949
Balance at Dec. 31, 2019	$ 29,000	77,434,000	(67,257,000)	10,206,000
Balance, shares at Dec. 31, 2019	29,478,338
Balance at Sep. 30, 2020	$ 30,000	79,582,000	(68,260,000)	11,352,000
Balance, shares at Sep. 30, 2020	30,620,990
Balance at Mar. 31, 2020	$ 30,000	79,352,000	(66,199,000)	13,183,000
Balance, shares at Mar. 31, 2020	30,531,949
Common stock issued for directors’ fees		46,000		46,000
Common stock issued for directors’ fees, shares	47,126
Stock Compensation Expense		74,000		74,000
Net Income (Loss)			(1,584,000)	(1,584,000)
Balance at Jun. 30, 2020	$ 30,000	79,472,000	(67,783,000)	11,719,000
Balance, shares at Jun. 30, 2020	30,579,075
Common stock issued for directors’ fees		58,000		58,000
Common stock issued for directors’ fees, shares	41,915
Stock Compensation Expense		52,000		52,000
Net Income (Loss)			(477,000)	(477,000)
Balance at Sep. 30, 2020	$ 30,000	$ 79,582,000	$ (68,260,000)	$ 11,352,000
Balance, shares at Sep. 30, 2020	30,620,990